Daily closing price · 250 sessions
Quantitative price outlook based on available market signals. Not financial advice.
Indicators calculated from the stored daily price history.
A verified, data-driven analysis will be generated here from price action, technical indicators, fundamentals, earnings and market context.
Dedicated research sections for 2026, 2030, 2035, 2040 and 2050. Numerical targets will appear only after the long-horizon model is validated.
Research inputs: earnings, revenue growth, valuation, technical regime, volatility, sector context and market conditions.
Read 2026 research →Research inputs: earnings, revenue growth, valuation, technical regime, volatility, sector context and market conditions.
Read 2030 research →Research inputs: earnings, revenue growth, valuation, technical regime, volatility, sector context and market conditions.
Read 2035 research →Research inputs: earnings, revenue growth, valuation, technical regime, volatility, sector context and market conditions.
Read 2040 research →Research inputs: earnings, revenue growth, valuation, technical regime, volatility, sector context and market conditions.
Read 2050 research →Only stories explicitly associated with this stock are shown.
TJX Companies raised its fiscal 2027 adjusted EPS guidance to $5.15-$5.20 following strong Q2 results that exceeded expectations. The company reported 11% earnings growth and 4% comparable sales growth, driven by higher merchandise margins and broad divisional gains. TJX also increased its long-term global store target by 500 locations to 7,500, planning 4% annual store growth from fiscal 2028. However, Marmaxx, the company's largest division, showed slower 1% comparable-sales growth, which management attributed to merchandise-mix issues.
TJX Companies raised fiscal 2027 EPS guidance and targets 5%-6% sales growth with plans to expand stores to 7,500 locations. However, the stock trades at a premium valuation (P/S ratio of 2.06 vs. industry 1.58) that leaves little room for execution errors. Key risks include Marmaxx underperformance and rising cost pressures, though strong cash generation supports growth and shareholder returns.
TJX Companies shares declined 17.4% in a month despite beating Q2 earnings expectations and raising fiscal 2027 guidance. While most divisions showed growth, Marmaxx comparable sales rose only 1%, below expectations due to merchandise mix issues. The company faces headwinds from higher wage and fuel costs, and its valuation premium leaves limited room for error.
TJX Companies' International division achieved significant profitability gains in Q2 FY2027, with adjusted segment profit margin rising 210 basis points year-over-year to 7.3%. The division reported net sales of $2.09 billion, up 11% from the prior year, driven by higher customer transactions and 7% comparable sales growth. The margin improvement was supported by favorable merchandise margins and expense leverage, while the company continued expansion efforts in Europe.
The article compares Chewy, a digital-first pet retailer with an 8.6B market cap, against TJX Companies, a brick-and-mortar off-price retail powerhouse with a 139B market cap. While Chewy offers a cheaper P/S ratio (0.7x vs 2.3x) and growing Autoship subscription revenue, TJX demonstrates superior profitability with a 9.1% net margin versus Chewy's 1.8%, a lower P/E ratio (23.3x vs 32.65x), and stronger free cash flow ($4.9B vs $562.4M). The author recommends TJX Companies as the better buy, citing its consistent ability to beat expectations, strong customer demand for value, and proven track record of profitability across economic cycles.
Common questions about price, predictions, long-term forecasts, technicals and research methodology.
TJX is currently shown at $122.84 in the latest stored market quote. The page is refreshed from the connected market-data pipeline.
A quantitative forecast is not currently available for TJX.
The 2026 long-term forecast section is included as a research framework. A numerical 2026 target is shown only after a dedicated long-horizon model has produced and validated it; the current 24H–90D model is not presented as a 2026 target.
The 2030 section tracks the inputs that a validated long-horizon model should use, including company growth, valuation, earnings, market regime and sector conditions. No unsupported price target is displayed.
The 2035, 2040 and 2050 sections are reserved for long-term model outputs. US Market AI does not invent numerical targets when validated long-horizon data is unavailable.
The page can display RSI, MACD, SMA 50, SMA 200, EMA 20, ATR, ADX, volatility, Bollinger levels, stochastic, support and resistance from stored daily price history.
Fundamental data is not currently populated for this stock, so the page does not estimate or fabricate missing values.
The latest ticker-linked news appears in the Market News section of this page. Stories are shown with source, publication date and sentiment when available.
There is not yet enough mature evaluation data on this page to claim a verified accuracy rate.
No. US Market AI provides research and model estimates for informational purposes. Forecasts can be wrong and should not be treated as personalized financial advice.
US Market AI combines quantitative signals and verified market data to support research. Forecasts are estimates, can be wrong, and are not financial advice.